Examples of using Multocida in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Pasteurella multocida related encephalitis or otitis interna.
Progressive atrophic rhinitis is caused by toxins from the bacteria Pasteurella multocida.
Pasteurella multocida is the most common bacteria to cause skin infections.
Infections of the respiratory tract caused by Pasteurella multocida, Actinobacillus pleuropneumoniae.
Pasteurella multocida, Escherichia coli
Pasteurella multocida.
Colonisation of the surface of the nasal mucosa by Pasteurella multocida is most often promoted by Bordetella bronchiseptica.
Pasteurella multocida, a natural host of the nasal cavity of rabbits, is often associated with middle and inner ear infection.
pasteurella multocida and mycoplasma.
Pasteurella multocida toxin, is produced by a method known as‘ recombinant technology.
With tilmicosin-susceptible microorganisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus.
Pasteurella multocida toxin, is produced by a method known as‘recombinant technology.
Pasteurella multocida and Haemophilus parasuis.
Pasteurella multocida, Actinobacillus pleuropneumoniae,
Colonisation of the surface of the nasal mucosa by Pasteurella multocida is most often promoted by Bordetella bronchiseptica.
Pasteurella multocida and Histophilus somni.
Mannheimia haemolytica, Pasteurella multocida and Histophilus somni,
Pasteurella multocida and Histophilus somni.
Dermonecrotic toxin producing Pasteurella multocida is the pathogen responsible for turbinate atrophy in progressive atrophic rhinitis.
Pasteurella multocida, Haemophilus parasuis,
Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia
The product is authorised with the indication the treatment of swine respiratory disease caused by Pasteurella multocida, Bordetella bronchiseptica and Mycoplasma hyopneumoniae.
Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia and require specific medication.
of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.
Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia and require specific medication.
randomized two-centred field trial using their final formulation to demonstrate efficacy for respiratory disease caused by P. multocida and B. bronchiseptica.
The vaccine contains a non-toxic recombinant derivative of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.
Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia and require specific medication.
Cefovecin exhibits in-vitro activity against Staphylococcus intermedius and Pasteurella multocida which are associated with canine and feline skin infections.
Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia